Avantor Announces CFO Resignation and Interim Finance Leadership

Avantor ( (AVTR) ) has issued an update.

Avantor announced that on March 26, 2026, Executive Vice President and Chief Financial Officer R. Brent Jones notified the company of his decision to resign to join a business outside the life sciences sector, triggering a transition period under his 90‑day notice requirement. To maintain continuity in its finance function, Avantor plans to appoint Senior Vice President and Chief Accounting Officer Steven Eck as interim CFO while it conducts an external search for a permanent successor.

Eck, who has served as Avantor’s chief accounting officer since 2019 and previously held senior finance roles at CSS Industries, Fidelity National Information Systems, Gardner Denver, General Electric and Deloitte, will retain his responsibilities as principal accounting officer during the interim period. In connection with his expanded role, Avantor has amended his compensation to include an additional $45,000 per month while serving as interim CFO and a $250,000 restricted stock unit award vesting over three years, underscoring the company’s focus on a stable financial leadership transition; the planned departure was disclosed in a press release issued on April 1, 2026.

The most recent analyst rating on (AVTR) stock is a Hold with a $7.50 price target. To see the full list of analyst forecasts on Avantor stock, see the AVTR Stock Forecast page.

Spark’s Take on AVTR Stock

According to Spark, TipRanks’ AI Analyst, AVTR is a Neutral.

The score is held back primarily by weakening fundamentals and uncertainty in the most recent financial snapshot, plus conservative 2026 guidance (continued organic revenue declines, margin contraction, and wide free-cash-flow range). Consistently positive cash flow and prior leverage improvement provide the main support, while bearish technicals and a negative P/E further pressure the overall rating.

To see Spark’s full report on AVTR stock, click here.

More about Avantor

Avantor, Inc. operates in the life sciences industry, providing products and services that support research, biopharma production, and specialized healthcare and industrial applications. The company focuses on supplying critical materials, consumables, and related solutions to customers across the global life sciences value chain, positioning itself as an enabling partner for innovation and regulated manufacturing.

Average Trading Volume: 11,712,528

Technical Sentiment Signal: Sell

Current Market Cap: $5.35B

See more data about AVTR stock on TipRanks’ Stock Analysis page.